Mode
Text Size
Log in / Sign up
N/A N=110 Randomized Treatment

ENgaging in Advance Care Planning Talks Group Visit Intervention

Advance Care Planning · Primary Health Care

Enrolled (actual)
110
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Presence of Medical Decision-maker Documentation in the EHR — 41; 38; 51; 40 participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
ENACT group visit (Behavioral); Mailed Resources (Behavioral)
Age
Adult, Older Adult · 50+ yrs
Sex
All
Sponsor
University of Colorado, Denver
Primary completion
May 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Presence of Medical Decision-maker Documentation in the EHR
41; 38; 51; 40
PRIMARY
Presence of Advance Directive in the EHR
24; 22; 39; 25
SECONDARY
Change in Advance Directive in Medical Record
24; 22; 38; 24; 39; 25
SECONDARY
Change in Readiness to Engage in ACP (ACP Engagement Score)
4.56; 4.13
SECONDARY
Change in Readiness to Chose a Surrogate Decision Maker
4.49; 4.25; 4.8; 4.39
SECONDARY
Change in Readiness to Discuss Values and Care Preferences With Surrogate Decision Maker
4.65; 4.25; 4.74; 4.28
SECONDARY
Readiness to Talk to Patient's Physician About Future Medical Care
3.47; 3.47; 3.99; 3.59
SECONDARY
Readiness to Sign Official Papers About Medical Care
4.24; 4.04; 4.69; 4.26

Summary

The main goal of the ENACT (ENgaging in Advance Care planning Talks) Group Visit intervention is to integrate a patient-centered advance care planning process into primary care, ultimately helping patients to receive medical care that is aligned with their values. The ENACT Group Visit intervention involves two group discussions about advance care planning with 8-10 patients who meet for 2-hour sessions, one month apart, facilitated by a geriatrician and a social worker. This study will compare the ENACT Group Visit intervention to mailed advance care planning materials.

Eligibility Criteria

Inclusion Criteria

  • 50 or older
  • Receive primary care through UCHealth, Colorado, USA.

Exclusion Criteria

  • Severe cognitive impairment, known diagnoses of dementia
  • Severe hearing loss or deafness
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03141242). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search